TBPH
Theravance Biopharma Inc.
$14.07
+$0.19(+1.37%)
66
Overall
--
Value
66
Tech
--
Quality
Market Cap
$698.51M
Volume
377.75K
52W Range
$7.88 - $14.55
Target Price
$20.00
EPS Estimates Overview
| Current Quarter | $-0.12 | Next Quarter | $0.11 |
| Current Year | $-0.46 | Next Year | $-0.69 |
| QoQ Growth | +191.7% | YoY Growth | -50.0% |
| 3Y EPS CAGR | +26.3% | Target Price | $20.00 |
| Consensus | Buy | Upside | +42.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TBPH | $14.07 | +1.4% | 377.75K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Theravance Biopharma Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW